However, PD-1 has been reported to have a higher expression on tumor-infiltrating CD8+ T cells in HNSCC, which resulted in dysfunction of PD-1+CD8+ T cells and tumor growth progression [88]. The gene discussed is CD8A; the disease is neoplasm.